Financials Shanghai Haixin Group Co., Ltd.

Equities

600851

CNE000000CF1

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
5.74 CNY +0.35% Intraday chart for Shanghai Haixin Group Co., Ltd. +7.69% -16.45%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 6,532 7,244 7,044 7,622 5,395 6,149
Enterprise Value (EV) 1 6,277 7,013 6,746 7,080 4,708 5,476
P/E ratio 62 x 93.4 x 82.1 x 81.2 x 43 x 49.9 x
Yield 0.5% 0.37% 0.37% 0.39% 0.77% 0.95%
Capitalization / Revenue 5.95 x 6.52 x 7.55 x 5.04 x 3.75 x 5.2 x
EV / Revenue 5.71 x 6.31 x 7.23 x 4.69 x 3.27 x 4.63 x
EV / EBITDA 107 x -193 x -128 x -107 x 137 x 76.5 x
EV / FCF -61.5 x -40.4 x -348 x -72.6 x -474 x -78.6 x
FCF Yield -1.63% -2.48% -0.29% -1.38% -0.21% -1.27%
Price to Book 2.45 x 2.52 x 2.34 x 2.6 x 1.84 x 2.09 x
Nbr of stocks (in thousands) 1,207,057 1,207,057 1,207,057 1,207,057 1,207,057 1,207,057
Reference price 2 6.940 8.040 8.120 8.880 5.850 6.870
Announcement Date 4/15/19 4/27/20 4/20/21 4/18/22 4/27/23 4/19/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,099 1,112 932.7 1,511 1,440 1,183
EBITDA 1 58.54 -36.26 -52.9 -66.18 34.33 71.58
EBIT 1 31.09 -62.83 -79.45 -89.64 11.05 48.68
Operating Margin 2.83% -5.65% -8.52% -5.93% 0.77% 4.12%
Earnings before Tax (EBT) 1 180.1 132.4 105.4 103.7 230.3 207.2
Net income 1 135.3 103.9 119.4 132.1 164.1 166
Net margin 12.31% 9.35% 12.8% 8.74% 11.39% 14.04%
EPS 2 0.1120 0.0861 0.0989 0.1094 0.1359 0.1376
Free Cash Flow 1 -102.1 -173.6 -19.38 -97.51 -9.928 -69.65
FCF margin -9.3% -15.62% -2.08% -6.45% -0.69% -5.89%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.0350 0.0300 0.0300 0.0350 0.0450 0.0650
Announcement Date 4/15/19 4/27/20 4/20/21 4/18/22 4/27/23 4/19/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 255 232 299 541 687 672
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -102 -174 -19.4 -97.5 -9.93 -69.7
ROE (net income / shareholders' equity) 4.12% 2.8% 2.33% 2.16% 4.78% 4.71%
ROA (Net income/ Total Assets) 0.41% -0.81% -0.92% -1.02% 0.13% 0.62%
Assets 1 32,717 -12,796 -12,963 -12,910 121,884 26,848
Book Value Per Share 2 2.830 3.190 3.470 3.420 3.180 3.280
Cash Flow per Share 2 0.2800 0.3200 0.3300 0.2700 0.3500 0.4200
Capex 1 106 239 155 74 15.9 61.8
Capex / Sales 9.66% 21.46% 16.6% 4.9% 1.11% 5.22%
Announcement Date 4/15/19 4/27/20 4/20/21 4/18/22 4/27/23 4/19/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 600851 Stock
  4. Financials Shanghai Haixin Group Co., Ltd.